Skip to main content
APTAMER GROUP PLC logo

APTAMER GROUP PLC — Investor Relations & Filings

Ticker · APTA ISIN · GB00BNRRP542 LEI · 213800Y4XGH3WJNBE686 IL Professional, scientific and technical activities
Open in API
Filings indexed 202 across all filing types
Latest filing 2024-08-01 Regulatory Filings
Country GB United Kingdom
Listing IL APTA

About APTAMER GROUP PLC

https://aptamergroup.com/

Aptamer Group PLC is a life sciences company that develops custom affinity binders to address targeting challenges in research, diagnostics, and therapeutics. The company's core technology is the Optimer® platform, which discovers and develops proprietary, next-generation aptamer-based binders. These Optimer binders are engineered for high specificity, stability, and manufacturability. The company provides custom development services, partnering with global pharmaceutical, diagnostic, and biotechnology organizations to support their programs from early discovery through to clinical development. Key application areas include the development of novel therapeutics, advanced diagnostic assays, bioprocessing workflows, and biomarker discovery.

Recent filings

Filing Released Lang Actions
Supplementary Conditional Placing for £60,000
Regulatory Filings Classification · 98% confidence The document is an official announcement released via RNS (RNS Number: 8748Y) on August 1, 2024. It details a 'Supplementary Conditional Placing for £60,000' due to a broker error, involving the issuance of 30,000,000 New Ordinary Shares. This announcement concerns fundraising, capital structure changes, and provides an update on total voting rights, which is relevant for shareholders. Since it is a specific announcement regarding financing/capital raising (a supplementary placing), the most appropriate category is 'Capital/Financing Update' (CAP). Although it is distributed via RNS, the content is highly specific to a capital event, making CAP more precise than the general 'RNS' fallback.
2024-08-01 English
Posting of Circular and Notice of General Meeting
Regulatory Filings Classification · 98% confidence The document is a short announcement (4050 characters) released via RNS (Regulatory News Service). The title explicitly states "Posting of Circular and Notice of General Meeting". It announces that the Circular and Notice of General Meeting have been despatched and provides the date and time for the General Meeting. According to Rule 2 (The "MENU VS MEAL" Rule), a short announcement stating that a document (like a Circular or Notice of Meeting) has been published or posted, without containing the full content of that document, should be classified as a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Since this specifically announces the publication of meeting materials (Circular and Notice), RPA is the most precise fit, as it signals the release of a formal document. If RPA were not available, RNS would be the fallback. Given the options, RPA is superior to RNS as it describes the action taken (publication announcement).
2024-07-24 English
Fundraise to Raise £2.83 million
Regulatory Filings Classification · 98% confidence The document is an official announcement from Aptamer Group PLC, identified by the RNS Number (6877X) and the use of the RNS distribution tracking image/header. The content details a significant capital raise (£2.83 million via Firm Placing, Conditional Placing, and Subscription), proposed board changes, grant of share options, and a Notice of General Meeting. This combination of corporate actions—fundraising, governance changes, and shareholder approval requirements—is characteristic of a major regulatory announcement on the London Stock Exchange's AIM market. Since it is a comprehensive announcement covering multiple material events (fundraising, board changes, options) released via the regulatory news service, it fits best under the general 'Regulatory Filings' category (RNS), as it is not a specific financial report (10-K, IR, ER) or a dedicated proxy/AGM document, but rather a broad disclosure of material information.
2024-07-24 English
Update on progress in Unilever partnership
Regulatory Filings Classification · 99% confidence The document is identified by the RNS Number (4042V) and the header indicating it is distributed via RNS, the news service of the London Stock Exchange, which is approved by the FCA as a Primary Information Provider. The content is a brief update on a partnership progress ('Update on progress in Unilever partnership') and includes contact information and boilerplate RNS disclaimers. It is not a full financial report (like 10-K or IR), nor is it a specific announcement like a dividend (DIV) or director dealing (DIRS). Since it is a general regulatory announcement distributed via RNS that doesn't fit a more specific category, the most appropriate classification is the general Regulatory Filings category (RNS). The document length is short (4560 chars) and functions as an announcement of ongoing business progress, fitting the general regulatory announcement scope.
2024-07-08 English
Trading Update
Earnings Release Classification · 99% confidence The document is identified by the RNS Number header and the closing statement indicating it is provided by RNS, the news service of the London Stock Exchange. The content is a 'Trading Update' for the year ending 30 June 2024, providing unaudited revenue figures (£0.85 million), order book status, and technical progress on key assets. This is a preliminary announcement of financial performance and operational highlights for a period, which aligns best with an Earnings Release (ER). It is not a comprehensive annual report (10-K) or a full interim report (IR), but rather the initial release of period-end results. FY 2024
2024-07-08 English
Agreement to explore Optimer vehicles for siRNA
Regulatory Filings Classification · 99% confidence The document begins with 'RNS Number : 8869U' and concludes with information about RNS, the news service of the London Stock Exchange, and an 'END' marker. The content announces a new agreement between Aptamer Group plc and AstraZeneca regarding siRNA delivery vehicles. This type of announcement, which is a general regulatory update distributed via the London Stock Exchange's RNS system, fits best under the 'Regulatory Filings' category, as it is not a specific financial report (like 10-K, IR, ER) or a specific corporate action (like DIV, CAP, DIRS). Although it is a specific announcement, RNS serves as the appropriate general regulatory disclosure category when other specific codes do not apply.
2024-07-03 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.